14 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Actelion - Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. The company is part of Johnson & Johnson Innovative Medicine business segment.
Amarin Corporation - Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Arena Pharmaceuticals - Arena Pharmaceuticals is a cardiovascular company headquartered in San Diego, CA, founded in 1997.
Cardiol Therapeutics - We are a seasoned and passionate team, committed to developing high impact and life changing therapies which heal the heart.
Cardurion Pharmaceuticals - Cardurion is the first company to successfully develop a CaMKII inhibitor and evaluate it in clinical studies. We are now well positioned to explore multiple cardiovascular diseases, including the rare and fatal genetic disease catecholaminergic polymorphic ventricular tachycardia (CPVT), as well as larger indications including heart failure and atrial fibrillation. PDE9 inhibition presents an opportunity to develop a foundational new treatment for patients with both types of chronic heart failu
Corvia Medical - The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality of life.
Cytokinetics - Cytokinetics is committed to developing potential medicines for people with diseases of impaired muscle function. Learn more about our medicines and research.
Daichi Sankyo - Daichi Sankyo is a cardiovascular brand headquartered in Tokyo, Japan, founded in 2005.
Eidos Therapeutics - BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
Esperion Therapeutics - Esperion Therapeutics is a cardiovascular brand headquartered in Ann Arbor, MI, founded in 2008.
Myokardia - Myokardia is a cardiovascular company headquartered in Brisbane, CA, founded in 2012.
Portola Pharmaceuticals - Our Innovation Pushing the Boundaries of Science Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.Learn how we are addressing some of today’s most pressing rare disease challenges by investigating in new targets, modalities and technologies, with more opportunities for innovation than ever before. To create meaningful advances in rare disease research, it takes an innovati
Tenaya Therapeutics - Here at Tenaya, we strive to make the needs of patients our top priority in all we do. As we develop new medicines aimed at targeting the genetic underpinnings of cardiomyopathies, we’ve sought input from patients and their families all along the way to better understand how genetic conditions like hypertrophic cardiomyopathy and arrhythmogenic right ventricular impact their lives daily and over time. We’ve also created resources to help patients, their families and their physicians better under
The Medicines Company - The Medicines Company is a cardiovascular company headquartered in Parsippany, NJ, founded in 1996.